Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Che-Yi Chou"'
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-6 (2024)
Abstract Background Sodium-glucose transporter-2 inhibitors (SGLT-2i) are recommended for use in patients with type 2 diabetes comorbid atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease. Limited reports are currently av
Externí odkaz:
https://doaj.org/article/928df423629a462696609b75dbabdb81
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 14, Iss 2, Pp 215-222 (2024)
Angiotensin II receptor blockers (ARBs) are one of the standard treatments for diabetic kidney disease (DKD). Some patients may opt for Chinese herbal medicine (CHM) of their own free will. However, there is no real-world evidence regarding the effec
Externí odkaz:
https://doaj.org/article/59f34e30ecf5487fb67f738d55c591e8
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-4 (2023)
Abstract Background Adequate fluid removal to achieve euvolemic status can be difficult in patients with incident peritoneal dialysis (PD). Limited treatments such as increased high dextrose PD solutions and icodextrin are currently available. We rep
Externí odkaz:
https://doaj.org/article/e8e0187a3c6a4bdd96ff15fd80396391
Publikováno v:
Biomedicines, Vol 12, Iss 4, p 791 (2024)
Chronic kidney disease (CKD) frequently correlates with cardiovascular complications. Soluble suppression of tumorigenicity 2 (sST2) and Galectin-3 (Gal-3) are emerging as cardiac markers with potential relevance in cardiovascular risk prediction. Th
Externí odkaz:
https://doaj.org/article/d704cf13c5a3457ea9340470ca441fbc
Autor:
Che-Yi Chou, Charles C. N. Wang, Hsiu-Yin Chiang, Chien-Fong Huang, Ya-Luan Hsiao, Chuan-Hu Sun, Chun-Sheng Hu, Min-Yen Wu, Sheng-Hsuan Chen, Chun-Min Chang, Yu-Ting Lin, Jie-Sian Wang, Yu-Cuyan Hong, I-Wen Ting, Hung-Chieh Yeh, Chin-Chi Kuo
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-8 (2023)
Plain language summary An enlarged heart occurs during various medical conditions and can result in early death. However, it is unclear whether this is also the case in patients with chronic kidney disease (CKD). Although the size of the heart can be
Externí odkaz:
https://doaj.org/article/c67c632a64fc4b2d8c8c47106d83a9ea
Autor:
Chao-Hsiun Tang, Che-Yi Chou
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Hip fracture is a significant health problem and is associated with increased mortality. Patients with chronic kidney disease (CKD) are more at risk of hip fracture than the general population, but the hip fracture risk is not evident among
Externí odkaz:
https://doaj.org/article/3cbe64df1f344d3e846dea4b473450a5
Autor:
Ni Tien, Bang-Jau You, Hsuan-Jen Lin, Chieh-Ying Chang, Che-Yi Chou, Hsiu-Shen Lin, Chiz-Tzung Chang, Charles C. N. Wang, Hung-Chih Chen
Publikováno v:
BMC Microbiology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Bacterial cultures allow the identification of infectious disease pathogens. However, obtaining the results of conventional culture methods is time-consuming, taking at least two days. A more efficient alternative is the use of co
Externí odkaz:
https://doaj.org/article/b63072ac69d64bfea4611efa7dccaa6d
Publikováno v:
BMC Urology, Vol 20, Iss 1, Pp 1-5 (2020)
Abstract Background Hypokalemia is a common clinical problem. The association between urinary tract infection (UTI) and hypokalemia is not clear. Hypokalemia is common in patients with UTI in clinical observation. The aim of the study is to determine
Externí odkaz:
https://doaj.org/article/a7b6df189633446dae715c0253a8a80c
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Urothelial cancer (UC) includes carcinomas of the bladder, ureters, and renal pelvis. New treatments and biomarkers of UC emerged in this decade. To identify the key information in a vast amount of literature can be challenging. I
Externí odkaz:
https://doaj.org/article/070379726127403699e75cc7cb70e9e9
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Acute Kidney Injury (AKI) is common among inpatients. Severe AKI increases all-cause mortality especially in critically ill patients. Older patients are more at risk of AKI because of the declined renal function, increased comorbi
Externí odkaz:
https://doaj.org/article/cd7e1e83e57e4bafb1c8a817760f27c5